Warberg Asset Management’s Oragenics OGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGEN
GWM
TSS
XT
LWM
MA
HSA
TRCT
Warberg Asset Management's OGEN Position: Q1 2025 in Review
Warberg Asset Management sold out of Oragenics (OGEN) in Q1 2025, closing a stake of 333 shares — an estimated $3.69K sold.
Warberg Asset Management first reported a position in OGEN in Q1 2024 and held it in 4 quarters. The position peaked at $72K in Q1 2024. 17 funds tracked by Wall St. Rank hold OGEN as of Q1 2025.
- Warberg Asset Management reported no remaining Oragenics position as of Q1 2025 after selling out during the quarter.
- Warberg Asset Management sold 333 Oragenics shares in Q1 2025, an estimated $3.69K.
- Warberg Asset Management first reported a position in Oragenics in Q1 2024 and held it in 4 quarters.
- Warberg Asset Management's Oragenics position peaked at $72K in Q1 2024.
- 17 funds tracked by Wall St. Rank held Oragenics as of Q1 2025.
Based on Warberg Asset Management's 13F filing for Q1 2025, filed 9 May 2025.